|
Patient
|
Site of Lesion
|
Baseline
|
1st assessment
|
2nd assessment
|
|---|
|
Diameter (mm)
|
SUVmax
|
Diameter (mm)
|
SUVmax
|
Response
|
Diameter (mm)
|
Response
|
|---|
|
1
|
kidney (primary)
|
63
|
7.5
|
65
|
3.7
|
SD
|
62
|
SD
|
|
LN
|
60
|
7.6
|
61
|
6.3
| |
60
| |
|
lung
|
10
|
1.5
|
10
|
1.6
| |
7
| |
|
2
|
bone
|
49
|
5.4
|
50
|
5.0
|
SD
|
54
|
PDa
|
|
lung
|
27
|
3.5
|
29
|
3.3
| |
33
| |
|
lung
|
12
|
2.8
|
14
|
2.2
| |
14
| |
|
3
|
lung
|
39
|
8.8
|
28
|
8.5
|
SD
|
18
|
PR
|
|
subcutaneous
|
13
|
1.9
|
10
|
1.0
| |
4
| |
|
4
|
bone
|
65
|
5.9
|
57
|
4.7
|
SD
|
60
|
SD
|
|
adrenal
|
45
|
3.7
|
45
|
3.6
| |
60
| |
|
bone
|
41
|
3.4
|
38
|
3.3
| |
35
| |
|
5
|
subcutaneous
|
161
|
5.1
|
151
|
6.7
|
SD
|
90
|
PR
|
|
adrenal
|
38
|
5.1
|
39
|
6.3
| |
21
| |
|
liver
|
33
|
4.5
|
38
|
5.4
| |
23
| |
|
LN
|
15
|
3.4
|
12
|
3.4
| |
0
| |
|
lung
|
12
|
5
|
12
|
5.4
| |
12
| |
|
muscle
|
45
|
4.2
|
45
|
5.6
| |
31
| |
|
bone
|
15
|
2.8
|
14
|
3.5
| |
0
| |
|
subcutaneous
|
15
|
2.1
|
14
|
3.7
| |
0
| |
|
6
|
lung
|
18
|
4.1
|
19
|
2.0
|
SD
|
8
|
PR
|
|
lung
|
23
|
3.5
|
20
|
6.3
| |
11
| |
|
adrenal
|
28
|
2.5
|
28
|
5.1
| |
21
| |
|
7
|
LN
|
15
|
3.3
|
15
|
2.9
|
SD
|
6
|
PR
|
|
lung
|
36
|
4.8
|
36
|
4.2
| |
17
| |
|
8
|
lung
|
22
|
5.1
|
17
|
6.1
|
SD
|
10
|
SD
|
|
lung
|
17
|
2.2
|
14
|
3.0
| |
5
| |
|
adrenal
|
32
|
3.7
|
34
|
2.8
| |
41
| |
|
9
|
lung
|
42
|
4.0
|
34
|
3.4
|
SD
|
13
|
PR
|
|
LN
|
16
|
4.8
|
10
|
3.0
| |
8
| |
|
LN
|
15
|
3.4
|
15
|
3.2
| |
15
| |
- PR Partial response, SD Stable disease, PD Progressive disease
- aPD: appearance of new lesion
